# Andrey Loboda

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andrey-loboda/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,290 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 51 |
| i10-index | 97 |
| Last Known Institution | Merck & Co., Inc., Rahway, NJ, USA (United States) |
| OpenAlex ID | https://openalex.org/A5060841115 |
| ORCID iD | https://orcid.org/0000-0003-4239-184X |
| Works | 292 |

## Researcher papers

- [Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection](https://scholariq.org/papers/hematopoietic-mosaic-chromosomal-alterations-increase-the-risk-for-diverse-types/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)
- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)

## Researcher university

- [Merck & Co., Inc., Rahway, NJ, USA (United States)](https://scholariq.org/institutions/merck-and-co-inc-rahway-nj-usa-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.